It is worth noting that there was a higher number of CD8+ cells observed in the pmlMS patient during the treatment period with respect to HD and a high number of CD4+ cells that decreased sharply at the time of PML diagnosis, leading to a reduction in the CD4/CD8 ratio that was not present in the other nMS patients. The gene discussed is CD4; the disease is progressive multifocal leukoencephalopathy.